SkinHealth Systems Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
SkinHealth Systems Inc. (SKIN) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$26.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-06
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$28.11M, a 1855.72% decline year-over-year.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $1.60M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$77.27M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$36.89M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$142.60M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$149.00M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$47.20M.
- SkinHealth Systems Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$330.71M, a 137.04% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.87M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$28.11M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$142.60M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | -$155.91M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$163.67M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$149.00M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | -$163.84M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$171.86M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$77.27M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$47.20M 10-K · filed 2026-03-12 | |||
| 2023-09-30 | -$8.51M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$19.69M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$36.89M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$330.71M 10-K · filed 2025-03-12 | |||
| 2022-09-30 | -$220.01M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$80.87M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$42.68M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $892.94M 10-K · filed 2024-03-12 | |||
| 2021-09-30 | $709.98M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $91.99M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $4.65M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $2.02M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $25.00K 10-Q · filed 2020-11-16 | $4.47M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $7.48M 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | $3.83M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |